Cited by 66Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome

Moran, Lisa J., Noakes, Manny, Clifton, Peter M., Wittert, Gary A., Belobrajdic, Damien P., Norman, Robert J.·2007·The Journal of Clinical Endocrinology & Metabolism

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with reproductive and metabolic abnormalities. It is unknown whether overweight women with and without PCOS achieve similar benefits from weight loss for cardiovascular risk factors. METHOD: Overweight body mass index-matched women with (n = 15) and without (n = 17) PCOS (weight, 95.3 +/- 17.6 kg; body mass index, 35.6 +/- 5.3 kg/m(2), mean +/- sd) followed an 8-wk weight loss regime. RESULTS: All subjects had similar reductions in weight (3.9 +/- 3.6 kg, 3.8%, vs. 4.5 +/- 4.1 kg, 4.7%, respectively, for PCOS and non-PCOS), waist circumference, fat mass, triglycerides, free testosterone, and fasting and postprandial insulin. At baseline, C-reactive protein (CRP) between groups was not significantly different (5.5 +/- 3.1 mg/liter for PCOS vs. 4.9 +/- 3.0 mg/liter for non-PCOS). There was a significant interaction between PCOS status and CRP (P = 0.016) such that CRP decreased with weight loss for non-PCOS women (-1.2 +/- 1.8 mg/liter; P = 0.025) but not for PCOS women. For all women, the change in CRP correlated with the change in weight (r = 0.560; P = 0.003), fat mass (r = 0.477; P = 0.016), and postprandial insulin (r = 0.402; P = 0.046). Adiponectin, IL-6, and TNF-alpha were not significantly different between groups before or after weight loss. Only subjects with baseline CRP levels below the median (4.52 mg/liter) showed increases in adiponectin (0.98 +/- 1.3 microg/liter) (P = 0.015) and greater reductions in triglycerides (P = 0.001) with weight loss. CONCLUSION: A 4-5% weight loss improved lipid, glucose, and insulin profiles in women with and without PCOS. This degree of weight loss was not effective in lowering CRP concentrations in PCOS women, suggesting that greater weight loss is required in this group to achieve equivalent cardiovascular benefit to non-PCOS women.

Integrity signals

Registry

Crossref · 10.1210/jc.2006-2336

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Moran, L. J., Noakes, M., Clifton, P. M., Wittert, G. A., Belobrajdic, D. P., & Norman, R. J.
Affiliations
  • Commonwealth Scientific and Industrial Research Organisation (AU)
  • The University of Adelaide (AU)
Corresponding author
Norman, Robert J.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2007-08-01
Volume
92
Issue
8
Pages
2944-2951
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2062737331
Cited by
66
References
56
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 4 · 2019: 1 · 2017: 2 · 2016: 6 · 2015: 3 · 2014: 3 · 2012: 8
FWCI
8.10
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders
  • Sanofi
  • Commonwealth Scientific and Industrial Research Organisation
  • Meat and Livestock Australia
  • University of Adelaide
  • Medical Research Council
  • National Health and Medical Research Council
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
polycystic ovary syndrome, C-reactive protein, weight loss, overweight women, cardiovascular risk factors, insulin resistance, adiponectin, inflammatory cytokines, triglycerides, free testosterone, waist circumference, fat mass, adipose tissue inflammation, lifestyle intervention, insulin sensitivity, dyslipidemia, hyperandrogenism
MeSH terms
Adult, Anthropometry, Body Composition, C-Reactive Protein, Eating, Female, Humans, Menstruation, Middle Aged, Motor Activity, Obesity, Polycystic Ovary Syndrome, Gonadal Steroid Hormones, Smoking, Tumor Necrosis Factor-alpha, Weight Loss, Interleukin-6, Body Mass Index, Diet, Carbohydrate-Restricted, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review